Pack Design For EU Orphan Drug Launch
Source: Almac Group
Almac was engaged by a virtual, US based Pharmaceutical client seeking EU commercial product approval for their first commercial product – an ultra-orphan, solid oral dose presentation. This EU launch project required designing both the primary and secondary packaging formats (blister / wallet) and origination of country-specific artwork to comply with individual EU market requirements.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
This website uses cookies to ensure you get the best experience on our website. Learn more